image description

Tag: BDCA2

Positive Study Results in Potential Treatment for Cutaneous and Systemic Lupus

December 3, 2019 The Lupus Research Alliance (LRA) is pleased to share positive results reported by Biogen Inc. from the Phase 2 LILAC study which tested the effectiveness and safety of a potential lupus treatment, BIIB059. BIIB059 is a monoclonal antibody that targets BDCA2, a protein found on cells known as plasmacytoid dendritic cells, which […] Read More
Stay informed about events, research developments, and ways you can help. Sign up for updates